From rabbits to unicorns: Healthcare visionary Homan Panahi will be the keynote speaker at the NOME Annual Meeting NOME is delighted to announce Homan Panahi, CEO of Vator Securities, as this year’s [...]
Novo Nordisk Foundation impact report on NOME NOME, a Novo Nordisk Foundation (NNF) initiative, supports promising life science start-ups by connecting them with very experienced life science professionals to help increase their [...]
Want to be part of NOME? The start-up competition has begun Getting access to mentors is a great way for life science start-ups to go from idea to commercialization. Biotech company Cellevate [...]
Boston to Durham - 4th NOME US trip In June 2018, four NOME companies, Cellevate, Draupnir.Bio, Monsenso and STipe Therapeutics, joined NOME on its annual US trip. This 4th NOME US trip [...]
SAGA Diagnostics Raises €1.0 Million Seed Capital from International Investors Swedish NOME start-up SAGA Diagnostics AB is a cancer genome testing company that offers unique, ultrasensitive tests and services to analyze the [...]
Antag Therapeutics raises 3M USD in a Series A investment from Novo Seeds The global prevalence of diabetes has nearly doubled since 1980, rising from 4,7 % to 8,5% in the adult [...]
NOME welcomes four new high-potential Nordic life science startups NOME (The Nordic mentor network for entrepreneurship) has engaged with four exciting life science startups. These companies come from a diverse range of [...]
